FRIDAY, JULY 21, 2017

Penn State study shows killer T cells critical to vaccines

Researchers from Penn State have discovered the human immune system needs enough killer T cells to respond to viral threats, which may be a critical component for more effective vaccines in the future. Read More »

Health Department: State's Lyme disease cases surge last year

The Pennsylvania Department of Health released a report last week on 2014's Lyme disease cases by county. The report showed a 25 percent increase in cases overall throughout the state, with 7,400 total cases last year, compared with 5,900 cases in 2013. Health experts attribute the surge to better reporting, improved awareness of Lyme disease and heightened monitoring efforts, especially in Allegheny County. Read More »

Pennsylvania officials find West Nile virus sample

The Pennsylvania Department of Environmental Protection (DEP) and Health Department have confirmed the year's first West Nile virus detection from a mosquito sample collected in Springettsbury Township, York County, on May 22.  Read More »

Inovio and GeneOne collaborate for MERS treatment development

Inovio Pharmaceuticals Inc. has partnered with GeneOne Life Science Inc., an international developer and manufacturer of DNA vaccines and an equity interest of Inovio, to further advance Inovio’s DNA vaccine for Middle East Respiratory Syndrome (MERS). Read More »

Alex Martin named CEO of PuriCore

Martin will be based at company's headquarters in Pennsylvania. Read More »

Hepatitis B Foundation gala observes 50th anniversary of virus's discovery

The Hepatitis B Foundation recently hosted the 2015 Crystal Ball, which observed the 50th anniversary of the discovery of the hepatitis B virus. The event included a live auction, a silent auction, dancing and an awards ceremony with a large crowd of supporters. The event raised $110,000 for outreach, research and patient-advocacy programs to eradicate hepatitis B. Read More »

Study shows GSK vaccine protected children from malaria

RTS,S vaccine could be especially valuable to areas of sub-Saharan Africa, where malaria is endemic. Read More »

GSK finishes transaction with Novartis

GlaxoSmithKline plc (GSK) completed a three-part transaction agreement with Novartis on Monday. Read More »

GlaxoSmithKline undergoing board changes

According to a recent announcement from GlaxoSmithKline (GSK), the company is undergoing several changes to its Board, including the fact that Sir Philip Hampton will take the place of Sir Christopher Gent as the Chairman of the GSK Board. Sir Philip originally joined the GSK Board on January 1, 2015. Read More »

GSK buys GlycoVaxyn AG

GSK announced today that it has bought GlycoVaxyn AG, a Swiss specialty vaccine biopharmaceutical company Read More »

Researchers: Telomeres may be key to fighting diseases

Researchers have discovered that rearranging pieces of DNA called telomeres help diseases like herpes flourish and may be key to fighting such illnesses in the future. Read More »

Vaccine researcher Plotkin to be presented with prestigious Hamdan Award

Dr. Stanley A. Plotkin, a renowned vaccine researcher, will be presented the Hamdan Award for Medical Research Excellence in the field of Vaccines on Dec. 16 at the Dubai International Conference for Medical Sciences. Read More »